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Abstract
Background: This controlled laboratory study was designed to evaluate the efficacy of the 10 % imidacloprid/4.5 %
flumethrin collar (Seresto®, Bayer Animal Health) against fleas (Ctenocephalides f. felis) on cats, when compared to
fipronil (9.8 %w/w)/(s)-methoprene (11.8 % w/w) topical spot-on formulation (Frontline® Plus for Cats and Kittens,
Merial).
Methods: Thirty cats were randomized into three groups of ten animals based on pre-treatment flea counts: Group
1: imidacloprid/flumethrin collar; Group 2: fipronil/(s)-methoprene topical spot-on and Group 3: non-treated
controls. The imidacloprid/flumethrin collars were applied one time on Day 0, while the fipronil/(s)-methoprene
spot-on was administered every 30 days from Day 0 through Day 210. Cats were infested with 100 fleas on study
days 0, 7, 14, 29, 59, 89, 119, 149, 179, 209 and 239. All flea counts were conducted by combing to remove fleas on
post-treatment days 2, 8, 15, 30, 60, 90, 120, 150, 180, 210 and 240.
Results: The efficacy of the imidacloprid/flumethrin collar ranged from 98.2 to 100 % for eight months. The efficacy
of fipronil/(s)-methoprene spot-on ranged from 68.2 to 99.9 %. Efficacy was < 85 % for fipronil/(s)-methoprene on
Days 90, 150 and 210. The flea counts in both treatment groups were significantly fewer than those in the non-
treated control group at every post-treatment study day (P < 0.0001). In addition, there were significantly fewer fleas
in the imidacloprid/flumethrin collar group when compared to the fipronil/(s)-methoprene group on Days 90, 150
and 210 (P < 0.0001).
Conclusions: This study demonstrated that the imidacloprid/flumethrin collar (Seresto®, Bayer Animal Health)
maintained excellent ( > 98.2 %) efficacy against fleas on cats for the entire 8 month study. Monthly applications of
fipronil/(s)-methoprene (Frontline® Plus for Cats and Kittens, Merial) generally had high, but variable (68.2 to 99.9 %)
efficacy over the course of the eight month study. Based on the very high residual efficacy achieved by the
imidacloprid/flumethrin collar in this study, veterinarians should expect that this collar will control and eliminate
existing flea infestations on cats and in their in-home premises as long as every flea infested host is treated.
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Background
The cat flea, Ctenocephalides felis felis is an extremely im-
portant external parasite of dogs and cats. Infestations of
pets and their surrounding premises can result in disease
and great distress for pets and their owners [1]. Historic-
ally, numerous different insecticides and insect growth
regulators have been used in a variety of formulations
(shampoos, sprays, dips, foams, injectable, spot-ons, col-
lars, powders and oral systemics) in attempts to control
fleas on dogs and cats [1, 2].
The impregnated collar delivery system was once popu-
lar and widely used for flea control [1, 2]. Historically, a
variety of insecticides such as carbaryl, chlorpyrifos, diazi-
non, dichlorvos, lindane, methylcarbamate, naled, propo-
xur, temophos and tetrachlorvinphos have been used in
these collars [1–8]. While various levels of efficacy were
clearly demonstrated in laboratory studies under con-
trolled conditions [3–7], questions often persisted con-
cerning their safety [9, 10] and their ability to manage an
active flea infestation when subjected to continual chal-
lenge in a naturally flea-infested environment [11]. The
inability of some of these collars to manage existing flea
infestations and their poor management of flea allergy
dermatitis may have been due to their slow residual speed
of kill. Two studies demonstrated that chlorpyrifos and
dichlorvos impregnated collars could not kill fleas fast
enough to stop flea reproduction [3, 8]. If fleas are laying
eggs, then they are living, feeding and injecting saliva for
at least 24 h on the collared pet. Clearly, if fleas continue
to reproduce on these collared pets then the infestation
could be sustained. Based on perceived issues of efficacy
and safety, use of insecticide impregnated flea collars
declined precipitously in popularity with veterinarians.
More recently newer insecticide collar formulations
have been introduced that contain either deltamethrin
or imidacloprid-flumethrin [12–14]. These collars have a
more prolonged activity against fleas and substantially
higher levels of residual efficacy [12–14]. Imidacloprid
and flumethrin are combined in a slow-release collar
formulation for both dogs and cats containing 10 % imi-
dacloprid (w/w) and 4.5 % flumethrin (w/w). It might be
assumed that the imidacloprid in the collar is for the
control of fleas, and the flumethrin is primarily for the
control of ticks. However, it has been demonstrated in-
vitro, using a Lepidoptera species, that there is synergis-
tic effect of imidacloprid on the flumethrin [15]. This
synergism may enhance the insecticidal properties of the
collar. In a previous study, when the imidacloprid-
flumethrin collars were placed on cats, flea control ran-
ging from 89.1–95.5 % was maintained for at least eight
months [13].
While these new collars appear to be a substantial ad-
vancement in formulation technology, topical spot-ons
still are a widely used insecticide application mode for
cats. One such product is a topical spot-on formulation of
fipronil/(s)-methoprene. Several laboratory controlled stud-
ies have reported that the monthly residual efficacy of the
topical spot-on formulation of fipronil/(s)-methoprene
applied to cats against C. f. felis ranges from 71.4 to 100 %
depending on study design and flea strain [16–19].
The purpose of this study was to compare and evalu-
ate the initial and residual efficacy of the imidacloprid
(10 % w/w)/flumethrin (4.5 % w/w) collar (Seresto®,
Bayer Animal Health) and the topical spot-on formula-
tion of fipronil (9.8 % w/w)/(s)-methoprene (11.8 % w/
w) (Frontline® Plus for Cats and Kittens, Merial) against
C. f. felis infestations on cats.
Methods
Animals
Cats were individually housed in cages for the duration of
the study, they were let out of their cages daily to exercise.
They were bathed with a mild, non-medicated shampoo,
thoroughly combed, and allowed to acclimate for 11 days
prior to the initiation of treatments. Concomitant treat-
ments were prohibited except where deemed necessary
and would not influence the performance of any product.
Cats were included if they were > 6 months old, deter-
mined to be healthy based on physical examination, not
pregnant, were able to harbour an adequate flea infest-
ation, and were not exposed to a previous insecticide
within 60 days of study onset. Initially, 36 purpose-breed
Domestic Shorthair (DSH) cats were evaluated for inclu-
sion in the study. One cat was removed on day −9 due to
a pre-existing health issue. The 35 remaining cats were
evaluated for the ability to harbor adequate flea infesta-
tions. Briefly, 35 cats were infested with approximately
100 non-fed, adult C. f. felis (Wildcat strain K-State) on
day -6. On study day -5, flea counts were performed to re-
move live fleas. Cats were then ranked by pre-study flea
counts in descending order and blocked in sets of 3. The
5 cats with the lowest flea counts were not included in the
study. The remaining 30 cats were subsequently random-
ized by a pre-selected randomization schedule in an at-
tempt to normalize the variability across treatment groups.
Ten cats were allocated to each treatment group, to ensure
that a minimum of 6 cats would be available for evaluation
at each time point. All animal care procedures conformed
to guidelines established by the Institutional Animal Care
and Use Committee at Kansas State University (IACUC
protocol No. 3181).
Experimental infestations
Cats were infested with approximately 100 C. f. felis on
study days 0, 7, 14, 29, 59, 89, 119, 149, 179, 209 and
239. Fleas used for all, but one infestation were from the
KSU Wildcat strain. For the infestation on Day 209, due
to a decrease in flea colony production, a different strain
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was used (BerTek). Flea counts were performed approxi-
mately 24 h following infestation except on Day 2 (48 h).
The entire body of each cat was groomed with a single-
sided, fine-tooth flea comb. Live fleas were collected, re-
moved, frozen, and counted. Flea removal was achieved
by combing each cat thoroughly for 10 min. If 5 or more
fleas were recovered during this period, the cat was
combed for an additional 5 min. If any fleas were recov-
ered during the second combing, the cats were combed
for an additional 5 min. Separate flea combs were used
for each cat.
Treatments
All products were applied in accordance with the manu-
facture’s guidelines and label recommendations. Cats were
weighed and dosage adjusted accordingly. Cats in group 1
were treated by placing an imidacloprid (10 % w/w)/flu-
methrin (4.5 % w/w) (Seresto®, Bayer Animal Health)
collar around their necks on day 0; the collars remained in
place for the duration of the 240 day (8 month) study.
Cats in group 2 were treated with a topical spot-on con-
taining fipronil (9.8 % w/w)/(s)-methoprene (11.8 % w/w)
(Frontline® Plus for Cats and Kittens, Merial) on Day 0 and
then monthly through Day 210. Following the initial treat-
ment on day 0, each of the 8 consecutive monthly treat-
ments occurred immediately following that month’s flea
removal. Cats in Group 3 served as non-treated controls.
Clinical monitoring
The cats were observed at least once daily during the
acclimation period and a physical examination was per-
formed on each cat 10 days prior to starting the study to
verify health status. On Day 0, cats were observed 1 and
4 h post application for adverse effects. For the remain-
der of the study, cats were observed daily until study
completion or removal from the study at which time a
physical examination was performed.
Efficacy determination
Total body live flea counts were determined and recorded.
Individual flea counts were used to calculate a geometric
mean (GM) for each group on the specified study days. For
each post-treatment flea count, efficacy was calculated using
Abbott’s Formula. Percent efficacy (% reduction) was deter-
mined by comparing the GM number of live fleas retained
on the treated group to the GM number of live fleas
retained on the non-treated negative control group. For ex-
ample: % efficacyControl ¼ GM flea count controlð Þ‐GM flea count treatmentð Þ100GM flea count controlð Þ
Data analysis
The assumption of equally distributed flea-ridding ability
was assessed by descriptively summarizing the pre-study flea
counts. The statistical method comparing post-treatment
flea counts included the pre-study flea counts for each
animal as the covariate. The efficacy of the treated groups,
relative to the non-treated control group, was computed
with Abbott’s formula. Geometric means were calculated
following transformation using a logarithmic method (aver-
aging the transformed values, and converting the average
using antilog to represent a GM). Because some animals
had zero flea counts, all counts were modified by adding
one to each prior to logarithmic transformation. Also, one
was subtracted from the antilog value to meaningfully
represent the GM for each group. Log flea counts (flea
count + 1) were analyzed with a repeated measures analysis
of covariance (RMANCOVA) including terms for treatment
(TRT), animal (random), study day (DAY), and the inter-
action of treatment and study day (TRT×DAY), using the
pre-treatment flea counts as a covariate. SAS PROC
MIXED Version 9.2 (SAS® Institute, Cary, NC) was used for
analysis with the covariance structures ‘CSH’, for data
collected on unequal intervals, which had the smallest
Akaike Information Criterion. The interaction of treatment
and study day was significant at the 0.05 level. The active
treatment groups were compared to the control through
the simple effect of TRT for each time point, with P-values
adjusted for multiple group comparisons (Bonferroni).
These simple effect pairwise comparisons were obtained
from the TRT×DAY interaction.
Results
The placement of a single imidacloprid/flumethrin collar
(Seresto®, Bayer Animal Health) provided 98.2 to 100 %
control of adult C. f. felis throughout the entire eight
month study (Table 1). The eight monthly applications
of fipronil/(s)-methoprene (Frontline® Plus for Cats and
Kittens, Merial) resulted in efficacy ranging from 68.2 to
99.9 % (Table 1). Efficacy was < 85 % for fipronil/(s)-
methoprene on Days 90, 150 and 210. The flea counts in
both treatment groups were significantly fewer than
those in the non-treated control group at every post-
treatment study day (t(251) < -5.45, P < 0.0001). In addition,
there were significantly fewer fleas in the imidacloprid/flu-
methrin collar group when compared to the fipronil/(s)-
methoprene group on Days 90, 150 and 210 (t(251) < -3.10,
P < 0.0001).
Clinical findings
Thirty cats, 17 males and 13 females, were included in the
study. All cats were over 6 months of age with a mean
weight of 3.5 kg (range 2.6–4.3 kg) 5 days prior to the start
of the study. A number of adverse events were reported in
all three treatment groups during the 8 month study.
Adverse events reported in the imidacloprid/flumethrin
collar group consisted of alopecia, erythema, abrasions,
and single episodes of vomiting and diarrhea (unknown if
product related). The alopecia could be attributed to the
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flea infestations and/or the mechanical irritation of the
collar. However, the erythema and abrasions were attrib-
uted to the collars as the cats were not used to something
around their neck. Of the adverse events in the fipronil/
(s)-methoprene group, the alopecia and pruritus were at-
tributed to the repeated flea infestations. However, one cat
had alopecia at the site of product application and one cat
developed diarrhoea. In the non-treated control group,
there was a single report of vomiting and the other obser-
vations were alopecia and abrasions likely associated with
repeated flea infestations.
Two cats in the imidacloprid/flumethrin collar group
were removed from the study due to hair loss, erythema,
and abrasions that developed underneath and next to the
collar; one was removed on study day 2 and the other on
study day 10. It appeared as though the cats were licking
or scratching at these areas and increasing the severity of
the lesions.
Discussion
The imidacloprid/flumethrin collar eliminated every flea
(100 % efficacy) within 48 h of collars being applied to
cats. This clearly demonstrates a rapid distribution of
insecticide from the collar. This collar also provided ≥
98.2 % control of flea infestations within 24 h of each re-
infestation for at least 8 months. In fact, the efficacy was
100 % within 24 h following five of the eight monthly re-
infestations. The 8 month residual efficacy of the imidaclo-
prid/flumethrin collar observed in this study was similar
too or higher than the previous reported efficacy range of
this collar on cats of 89.1–95.5 % [13].
Historically, insecticide impregnated flea collars likely
failed to control flea infestations because their residual
speed of flea kill was too slow to prevent fleas from
producing viable eggs [3, 8, 11]. Ctenocephalides f. felis
can initiate egg production within 24–48 h after females
acquire a host and take their first blood meal [20, 21].
Therefore, if a residual insecticide cannot kill newly
acquired fleas within 24 h, egg production could be
maintained and the infestation will be sustained gener-
ation upon generation. However, if the newly acquired
fleas can be killed prior to initiating reproduction, then
the infestation on the cat and in the surrounding prem-
ises will be eliminated because if a population cannot
reproduce it will be eradicated in the local in-home
environment [22, 23]. Based on the very high 24-h re-
sidual efficacy achieved by the imidacloprid/flumethrin
collar in this study, this collar should be able to control
and eliminate existing flea infestations on cats and in their
in-home premises as long as every flea infested host is
treated.
The fipronil/(s)-methoprene topical spot-on formulation
was generally efficacious against the C. f. felis strains used
in this study. Efficacy was 99.9 % within 48 h of application
and the 30 day residual was > 93.2 % following five of the
eight monthly applications. However, there were three
times that the 30 day residual efficacy dropped below 85 %.
This occurred on days 90, 150 and 210. It is unknown why
Table 1 Geometric (arithmetic) mean live flea counts and percent efficacy against the Wildcat strain of C. f. felis infesting cats
treated with either an imidacloprid/flumethrin collar or a fipronil/(s)-methoprene topical spot-on
Non-treated controlsd,g Imidacloprid/flumethrine,g Fipronil/(s)-methoprenef,g
Study day Mean No. of fleas Mean No. of fleas % controlh
Geomeans
Mean No. of fleas % controlh
Geomeans
2 55.0a (55.8) 0 (0) 100b 0.1 (0.1) 99.9b
8 55.3a (57.9) 0 (0) 100b 0.6 (1.0) 98.8b
15 52.0a (53.5) 0.9 (1.4) 98.3b 0.4 (0.7) 99.1b
30 47.0a (48.7) 0 (0) 100b 0.2 (0.4) 99.5b
60 35.7a (36.6) 0 (0) 100b 1.0 (2.5) 97.2b
90 40.4a (42.4) 0 (0) 100b 12.8 (15.7) 68.2c
120 38.8a (39.6) 0.1 (0.1) 99.8b 1.9 (4.0) 95.0b
150 45.9a (47.3) 0 (0) 100b 7.1 (10.4) 84.5c
180 38.3a (40.2) 0 (0) 100b 1.5 (2.6) 96.1b
210 46.8a (47.3) 0.1 (0.1) 99.8b 12.5 (14.0) 73.3c
240 48.5a (50.9) 0.9 (1.4) 98.2b 3.3 (4.1) 93.2b
d Each of 10 cats in the control group received no treatment
e Each of 10 cats in the imidacloprid/flumethrin group were fitted with a Seresto® collar (Bayer Animal Health) on day 0. Note that two cats were removed from
this group (one on study day 2 and one on study day 10)
f Each of ten cats in the fipronil/(s)-methoprene group were treated Frontline® Plus for Cats and Kittens (Merial) on day 0 and then monthly through day 210
g Each cat was infested with 100 adult C. f. felis on days 0, 7, 14, 29, 59, 89, 119, 149, 179, 209, and 239
h % efficacy/Control = (GM flea count (control) – GM flea count (treatment) × 100)/GM flea count
(control) % Control ¼ geometricmean count control‐geometric mean count treatmentgeometric mean count treatment  100
a,b,c Values across rows with unlike superscripts are significantly different (P < 0.0001)
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the efficacy was statistically lower following these infesta-
tions. While the BerTek strain was used for the day 209
infestation with a resulting 73.3 % efficacy for fipronil/(s)-
methoprene, following the day 90 infestation with the
Wildcat strain, the efficacy of the spot-on formulation was
68.2 %. Therefore, it does not appear that a different flea
strain can account for the reduced efficacy.
Another observation from the data is that it does not
appear that any significant bioaccumulation of fipronil
occurred following 8 consecutive monthly applications.
Efficacy 30 days following the eighth application was
93.2 % while the 30 day residual efficacy following the first
application was 99.5 %.
Based on post-launch pharmacovigilance data, and other
reports in the literature, the erythema, alopecia, and abra-
sions that developed underneath and next to the collars in
several of the cats in this study appears to be an uncom-
mon occurrence. A laboratory study that evaluated Barto-
nella henselae transmission to cats found that 0/8 cats
treated with the imidacloprid/flumethrin collar developed
lesions associated with the collar [24]. A clinical field study,
that evaluated the safety and efficacy of the imidacloprid/
flumethrin collar (n = 232) in cats naturally infested with
fleas and/or ticks revealed that 9.0 % of the imidacloprid/
flumethrin treated feline study population developed lesions
associated with the collar compared to 5.6 % of the control
population (n = 81); the difference was not statistically
significant (P > 0.05) [25]. Similar results were observed in a
second field comparison that evaluated 95 cats owned by
veterinary students or teaching hospital staff and treated
with either the imidacloprid/flumethrin collar or had a pla-
cebo collar applied. All dermal lesions were observed dur-
ing the first 14 days of wearing the collar and none of these
lesions were significantly different between groups. Multi-
variate analysis revealed that young cats that had not previ-
ously worn collars were significant covariates. The authors
concluded that cats that were originally intolerant of collars
became more receptive over time and the adverse events
observed in imidacloprid/flumethrin treated cat were simi-
lar to cats wearing a placebo collar and also to cats wearing
an identification collar reported in a previous study [26].
Therefore, the aforementioned studies suggest that the
adverse event results reported here are not consistent with
findings reported by other investigators or pharmaco-
vigilance data reported by Bayer Animal Health (per
communication with Drs. Cristiano Von Simson and Joe
Hostetler). The degree of collar associated lesions ob-
served in this study may be a reflection of cage confined
cats that were not used to wearing a collar and were
“worrying” at the new device. However, the results should
not be discredited and owners should observe their cats
occasionally, especially during the first few days of product
application, to ensure the collar is not placed too tightly
and that lesions do not develop.
Conclusions
This study confirmed that the imidacloprid/flumethrin
collar maintains excellent efficacy (98.2–100 %) against
fleas on cats for at least eight months. In addition, the imi-
dacloprid/flumethrin collar performed favourably to the
fipronil/(s)-methoprene topical spot-on, and the imidaclo-
prid/flumethrin collar group had significantly fewer fleas
when compared to the fipronil/(s)-methoprene group on
Days 90, 150 and 210. Based on the very high 24-h re-
sidual efficacy achieved by the imidacloprid/flumethrin
collar in this study, this collar should be able to control
and eliminate existing flea infestation on cats and in their
in-home premises as long as every flea infested host is
treated.
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